Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi® (ustekinumab-aauz)
Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
Press Release The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma ...
Medical Dialogues13d
Glenmark Pharma USA launches Epinephrine Injection
Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...